Literature DB >> 32758517

Gut-brain axis: A matter of concern in neuropsychiatric disorders…!

Muhammad Naveed1, Qi-Gang Zhou2, Chu Xu2, Abdoh Taleb1, Fan Meng2, Bilal Ahmed1, Yu Zhang1, Kohji Fukunaga3, Feng Han4.   

Abstract

The gut microbiota is composed of a large number of microbes, usually regarded as commensal bacteria. It has become gradually clear that gastrointestinal microbiota affects gut pathophysiology and the central nervous system (CNS) function by modulating the signaling pathways of the microbiota-gut-brain (MGB) axis. This bidirectional MGB axis communication primarily acts through neuroendocrine, neuroimmune, and autonomic nervous systems (ANS) mechanisms. Accumulating evidence reveals that gut microbiota interacts with the host brain, and its modulation may play a critical role in the pathology of neuropsychiatric disorders. Recently, neuroscience research has established the significance of gut microbiota in the development of brain systems that are essential to stress-related behaviors, including depression and anxiety. Application of modulators of the MGB, such as psychobiotics (e.g., probiotics), prebiotics, and specific diets, may be a promising therapeutic approach for neuropsychiatric disorders. The present review article primarily focuses on the relevant features of the disturbances of the MGB axis in the pathophysiology of neuropsychiatric disorders and its potential mechanisms.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anxiety; Bidirectional communication; Cognitive function; Depression; Gut microbiota; Microbiota-gut-brain axis; Schizoaffective disorders; Stress; Visceral pain; neurodevelopmental disorders

Year:  2020        PMID: 32758517     DOI: 10.1016/j.pnpbp.2020.110051

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  7 in total

Review 1.  Overall Rebalancing of Gut Microbiota Is Key to Autism Intervention.

Authors:  Chang Lu; Jiaqi Rong; Changxing Fu; Wenshi Wang; Jing Xu; Xing-Da Ju
Journal:  Front Psychol       Date:  2022-05-26

2.  Probiotic Lactobacillus fermentum strain JDFM216 improves cognitive behavior and modulates immune response with gut microbiota.

Authors:  Mi Ri Park; Minhye Shin; Daye Mun; Seong-Yeop Jeong; Do-Youn Jeong; Minho Song; Gwangpyo Ko; Tatsuya Unno; Younghoon Kim; Sangnam Oh
Journal:  Sci Rep       Date:  2020-12-10       Impact factor: 4.379

3.  Gut microbiota, innate immune pathways, and inflammatory control mechanisms in patients with major depressive disorder.

Authors:  Javier R Caso; Karina S MacDowell; Ana González-Pinto; Saínza García; Javier de Diego-Adeliño; Mar Carceller-Sindreu; Fernando Sarramea; Javier Caballero-Villarraso; Patricia Gracia-García; Concepción De la Cámara; Luis Agüera; María L Gómez-Lus; Claudio Alba; Juan M Rodríguez; Juan C Leza
Journal:  Transl Psychiatry       Date:  2021-12-21       Impact factor: 6.222

Review 4.  Dynamic and Systemic Perspective in Autism Spectrum Disorders: A Change of Gaze in Research Opens to A New Landscape of Needs and Solutions.

Authors:  Cristina Panisi; Marina Marini
Journal:  Brain Sci       Date:  2022-02-11

5.  Influence of Aging, Macronutrient Composition and Time-Restricted Feeding on the Fischer344 x Brown Norway Rat Gut Microbiota.

Authors:  Abbi R Hernandez; Keri M Kemp; Sara N Burke; Thomas W Buford; Christy S Carter
Journal:  Nutrients       Date:  2022-04-22       Impact factor: 5.717

Review 6.  The Role of Tryptophan Metabolites in Neuropsychiatric Disorders.

Authors:  Majid Davidson; Niloufar Rashidi; Kulmira Nurgali; Vasso Apostolopoulos
Journal:  Int J Mol Sci       Date:  2022-09-01       Impact factor: 6.208

Review 7.  Recent developments in the probiotics as live biotherapeutic products (LBPs) as modulators of gut brain axis related neurological conditions.

Authors:  Duygu Ağagündüz; Feray Gençer Bingöl; Elif Çelik; Özge Cemali; Çiler Özenir; Fatih Özoğul; Raffaele Capasso
Journal:  J Transl Med       Date:  2022-10-08       Impact factor: 8.440

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.